These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7684427)

  • 1. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Dutrieux RP; Das PK
    J Invest Dermatol; 1993 Jun; 100(6):816-22. PubMed ID: 7684427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of melanocyte-melanocyte stem cell lineage in vitiligo; a clue to interfollicular melanocyte stem cell reservoir.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ultrastruct Pathol; 2014 May; 38(3):186-98. PubMed ID: 24460782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentachrome vitiligo.
    Fargnoli MC; Bolognia JL
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):853-6. PubMed ID: 7593796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hair follicle melanocytes in vitiligo in relation to disease duration.
    Anbar TS; Abdel-Raouf H; Awad SS; Ragaie MH; Abdel-Rahman AT
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):934-9. PubMed ID: 19453793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanin and melanosome complexes in long standing stable vitiligo--an ultrastructural study.
    Bartosik J; Wulf HC; Kobayasi T
    Eur J Dermatol; 1998 Mar; 8(2):95-7. PubMed ID: 9649719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural study of vitiligo.
    Galadari E; Mehregan AH; Hashimoto K
    Int J Dermatol; 1993 Apr; 32(4):269-71. PubMed ID: 8486458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanisms of hypopigmentation in lichen sclerosus.
    Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A
    Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
    Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis.
    Elsherif R; Mahmoud WA; Mohamed RR
    Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo.
    Zailaie MZ
    Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
    Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.
    Norris A; Todd C; Graham A; Quinn AG; Thody AJ
    Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hair follicles in the repigmentation of vitiligo.
    Cui J; Shen LY; Wang GC
    J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
    Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
    Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.